pharmaceutical investing ObsEva SA Reports Positive Topline Results from IMPLANT2 Phase 3 Clinical Trial of Nolasiban in IVF
medical device investing Predictive Technology Announces Completion of Genotyping in Two Clinical Trials of ARTGuide
medical device investing ChroMedX CEO Lahav Gil Assembles Task-Force to Explore Feasibility and Applications of Automated Ultrafiltration Technology
medical device investing U.S. Patent and Trademark Office has granted to Todos Medical two additional patents
medical device investing ChroMedX Announces In-House Biosensor Manufacturing for Expedited Testing and Refinement; Appoints Edwards as Executive Chairman
medical device investing RepliCel CEO: Anticipating the Approval of Their Dermal Injector, its Impact in Europe and Beyond
Westport to Issue Q2 2025 Financial Results on August 11, 2025 and Provides an Update on the Divestment of the Light-Duty Segment
Blue Lagoon Resources Added to CSE25 Index - Recognized Among 25 Largest Companies on the Canadian Securities Exchange
SAGA Metals Mobilizes and Commences Summer Work Programs at Recently Drilled 100% Owned Radar Titanium Property in Labrador, Canada & Provides Corporate Update
RUA GOLD Closes C$13.8 Million Brokered Offering Including the Full Exercise of Over-Allotment Option
